Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease
Overview
Authors
Affiliations
Background: Anemia, iron deficiency, and hypovitaminosis D are well-known comorbidities in inflammatory bowel disease (IBD). Epidemiologic studies have linked vitamin D deficiency with increased risk of anemia, and in vitro studies suggest that vitamin D may improve iron recycling through downregulatory effects on hepcidin and proinflammatory cytokines.
Methods: We aimed to investigate the association of vitamin D status with inflammation, iron biomarkers, and anemia in pediatric IBD. Cross-sectional data were obtained from N = 69 patients with IBD aged 5 to <19 years. Iron biomarkers (ferritin, soluble transferrin receptor), and 25-hydroxyvitamin D (25(OH)D), inflammatory biomarkers (C-reactive protein and α-1-acid glycoprotein), hepcidin, and hemoglobin were collected. Iron biomarkers were regression corrected for inflammation. Multivariable logistic/linear models were used to examine the associations of 25(OH)D with inflammation, iron status, hepcidin, and anemia.
Results: Approximately 50% of subjects were inflamed (C-reactive protein >5 mg/L or α-1-acid glycoprotein >1 g/L). Iron deficiency prevalence (inflammation-corrected ferritin <15 μg/L or soluble transferrin receptor >8.3 mg/L) was 67%; anemia was 36%, and vitamin D insufficiency (25(OH)D <30 ng/mL) was 77%. In linear regression models, vitamin D insufficiency was associated with increased hepcidin levels (β [SE] = 0.6 [0.2], P = 0.01) and reduced hemoglobin (β [SE] = -0.9 [0.5], P = 0.046), controlling for age, sex, race, insurance status, body mass index for age, inflammation, disease diagnosis (ulcerative colitis versus Crohn's disease), and disease duration, compared with 25(OH)D ≥30 ng/mL.
Conclusions: Our results suggest that concentrations of 25(OH)D ≥30 ng/mL are associated with lower hepcidin and higher hemoglobin levels. Further research is needed to clarify the association of vitamin D with inflammation, iron status, and anemia in pediatric IBD.
Andres B, Rasool A, Pepich G, Hsu C, Taleban S Ann Gastroenterol. 2024; 37(5):536-542.
PMID: 39238798 PMC: 11372540. DOI: 10.20524/aog.2024.0900.
The interplay between vitamin D status, subclinical inflammation, and prediabetes.
Arabi A, Nasrallah D, Mohsen S, Abugharbieh L, Al-Hashimi D, AlMass S Heliyon. 2024; 10(15):e35764.
PMID: 39170232 PMC: 11337041. DOI: 10.1016/j.heliyon.2024.e35764.
Nutritional Modulation of Hepcidin in the Treatment of Various Anemic States.
DAndrea P, Giampieri F, Battino M Nutrients. 2023; 15(24).
PMID: 38140340 PMC: 10745534. DOI: 10.3390/nu15245081.
Pivac I, Jelicic Kadic A, Despot R, Zitko V, Tudor D, Runjic E Children (Basel). 2023; 10(10).
PMID: 37892340 PMC: 10605261. DOI: 10.3390/children10101677.
Fatahi S, Alyahyawi N, Albadawi N, Mardali F, Dara N, Sohouli M Front Nutr. 2023; 9:1007725.
PMID: 36698467 PMC: 9868587. DOI: 10.3389/fnut.2022.1007725.